Answers are grounded in this paper and cite their sources.
Neoadjuvant chemoradiotherapy (NCRT) followed by total mesorectal excision (TME) is recommended for locally advanced rectal cancer in clinical practices. With the aim of improving the long-term quality of life and functional outcomes of patients who have achieved clinical complete response (cCR), the watch-and-wait (W&W) strategy could be considered a treatment option [1, 2]. However, some patients who achieved a cCR may develop local regrowth [3]. Local regrowth occurs in the intraluminal aspect of the primary tumor bed in almost 90% of patients [4], whereas extraluminal local regrowth is rare. Herein, we reported a case of local regrowth of a tumor deposit (TD) during W&W surveillance. We aim to draw attention to emerging extraluminal lesions by analyzing the radiological features of the TD. This paper was written in compliance with the SCARE Guideline. A 76-year-old man with rectal cancer presented at our hospital (Peking Union Medical College Hospital, Beijing, China). He was diagnosed with rectal cancer during a medical checkup without any complaints. He had hypertension but no history of drugs or allergies. He had no surgical history. Colonoscopy revealed the distance between the upper edge of the tumor and the anal verge was 3 cm. Histopathological examination of the biopsy specimen revealed a moderately differentiated adenocarcinoma with mismatch repair proficient (pMMR). Rectal magnetic resonance imaging (MRI) revealed a lesion (2 cm in length) that invaded the muscularis propria with enlarged regional lymph nodes (the largest one was 6 mm in diameter) (Figure 1); however, no extramural vascular invasion (EMVI) was found. CT did not reveal any metastases to distant sites. Laboratory results showed normal levels of carcinoembryonic antigen (CEA) and carbohydrate antigen 19–9 (CA19-9). A digital rectal examination revealed that the tumor was adjacent to the anorectal junction. Therefore, locally advanced rectal cancer (cT2N2M0) was diagnosed. Images of patients during diagnosis and treatment. (A) Colonoscopy and T2-weighted and diffusion-weighted images of the primary lesion and suspicious lymph node at different times. The white arrows and green arrows show the primary lesion did not have deterioration during watch-and-wait. The red arrows show the node was getting greater and higher diffusion-weighted signal at 10 months of watch-and-wait. (B) Gross pathological examination shows the primary lesion (green arrow) and the firm nodule (red arrow). The specimen was tattooed by a surgeon with ink to indicate the circumferential resection margin. (C): The T2-weighted images of 14-month assessment show the tumor deposit and its associated vessel (white arrow). (D) Hematoxylin and eosin slide (magnification ×10) of the nodule shows moderately differentiated adenocarcinoma (yellow star) and vascular invasion adjuvant to the deposit (red star). The patient underwent NCRT (total dosage of 50 Gy of radiation with two cycles of concomitant capecitabine chemotherapy) without adverse effects. Assessments were repeated at seven weeks after the end of radiation. A colonoscopy revealed a flat white scar without telangiectasias or ulceration. Rectal MRI showed low T2-weighted signals and low diffusion-weighted signals in the primary lesion and regional lymph nodes. A digital rectal examination revealed no abnormalities. Thus, the patient achieved cCR at that time and entered into the W&W surveillance without consolidation chemotherapy following informed about the risk of tumor regrowth and metastasis. As shown in Figure 1A, the primary lesion did not show any deterioration in radiological features during W&W surveillance. However, the suspicious regional lymph node was enlarged (5.9 mm in diameter) and showed a high diffusion-weighted signal at 10 months of assessment, indicating local regrowth. The patient refused the proposed surgery because of personal preference. Assessment at 14 months revealed that the nodule was larger than before (9 mm in diameter). Ultimately, the patient underwent salvage laparoscopic abdominoperineal resection with D3 dissection. The postoperative course of the patient was uneventful, and the patient was discharged from the hospital. Pathological examination revealed that the moderately differentiated adenocarcinoma (pMMR) had infiltrated the submucosa, muscularis propria, and extramural adipose tissue. We analysed the clinical and imaging data, and found that the adenocarcinoma was located at 3 cm on the oral side of the dentate line in the mesorectum, which was not the location of the primary tumor. The scar-like primary lesion adjacent to the dentate line was tumor-free (Figure 1B). Combining all the data, we considered the existing tumor to be a local regrowth. The lymph nodes within the mesorectum and the inferior mesenteric artery area did not show any evidence of metastasis. However, the tumor cells were found at the location less than 1 mm from the resection margin. Thus, the final stage of this patient was ypT0N1c, according to the 8th edition of the TNM Classification. The patient received adjuvant chemoradiotherapy due to a positive circumferential resection margin. The incidence of local regrowth is 20%–25% in patients with rectal cancer who are managed by W&W after cCR [5]. Local regrowth is most frequently diagnosed in the first two years of follow-up and is most commonly located in the rectal wall [4], whereas the extraluminal local regrowth is rare. The challenge is to timely and accurately detect local regrowth. The signs of extraluminal regrowth included nodule enlargement and changes in contour features [6]. Conformational change, increase in size, intermediated tumor signal on T2-weighted MRI, and high signal on diffusion-weighted MRI could indicate regrowth. Tumors may regrow as TDs wherein only fat or vessels were present before [7]. Discontinuous from the primary lesion, TDs can be distinguished from lymph nodes because they cannot be separated from the vein and tend to taper into the vein (described as a comet-tail appearance) rather than being alongside the vein [8]. As for the present case, the radiologist observed that the suspicious nodule was becoming larger in size, irregular in contour, and exhibiting signal intensity on diffusion-weighted imaging. Additionally, the identification of a penetrating vessel of the nodule led to the consideration that it might be a TD (Figure 1C). The pathologist found vascular invasion near the nodule but no evidence of lymphatic structure (Figure 1D). Therefore, the regrown nodule in the mesorectum was diagnosed as a TD. TD is the extension of tumor cells into the peri-nodal tissue and is associated with lymph node metastasis, vascular invasion, and perineural invasion. Lord et al. [9] proposed that TD may result from tumor fragmentation and regression after NCRT, where islands of tumor cells are present within the mesentery as remnants of the previous tumor. Whether the phenomenon was a primary tumor or a secondary uncontrolled primary tumor is unknown. However, this phenomenon cannot be neglected because of the worse oncological outcomes. Shorter intervals between local regrowth and salvage resection may be associated with a lower risk of advanced pathological stage and distant metastases [10]. However, failure to detect regrowth in time and failure to perform resection without delay was attributed to the positive circumferential resection margin in this case. TD may have more aggressive biological characteristics. Therefore, strict surveillance of patients is strongly recommended. The radiologist could determine the location of the tumors that were present before and post-NCRT by MRI. They can also monitor the radiological features of the entire pelvis as mentioned before. Salvage resection should be recommended as early as possible after the diagnosis of local regrowth. Careful evaluation of the rectal wall and mesorectum using rectal MRI is essential for the timely detection of local regrowth. Patients diagnosed with local regrowth should undergo salvage resection as soon as possible. Z.S., Y.X., and J.L. interpreted data and drafted the article. G.Z. participated in data acquisition and interpretation, W.Z. and Y.X. designed the project and supervised the article. All authors have read and agreed to the published version of the manuscript. This work was supported by National High-Level Hospital Clinical Research Funding (2022-PUMCH-C-027). This study was approved by the Ethics Committee of Peking Union Medical College Hospital (K2733). The patient gave written informed consent for this case report to be published. The authors declare that there is no conflict of interest in this study.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: